IRF2BP2 knockdown in HeLa cells led to an upregulation of EGFR which may contribute to enhanced proliferation in response to EGF, a potent regulator of cellular growth as well as in cancer progression (Barysch et al., 2021). This evidence concerns the gene IRF2BP2 and cancer.